J&J to acquire Connecticut biotech in $3.05B oncology dealBy jay.trebleNovember 18, 2025Listen to this article The basics: J&J to acquire Halda Therapeutics in $3.05B oncology-focused deal Acquisition adds prostate cancer therapy HLD-0915 and early-stage tumor candidates Strengthens…
3
4
5
